Abstract withdrawn as it was not presented at the Meeting P39 - Can advances in molecular methods improve the management and outcomes of Non-Tuberculous Mycobacterial Lung Disease (NTM-LD)? A service evaluation of laboratory and clinical management of NTM-LD in a large teaching hospital in England Amendments to text in abstracts P189 - Use of Angiotensin-Converting-Enzyme Inhibitors and Angiotensin Receptor Blockers in COVID-19 infection does not adversely affect clinical outcomes including need for Non-Invasive and Invasive Ventilation Introduction It has been hypothesised that use of Angiotensin-Converting-Enzyme Inhibitors (ACE-I) and Angiotensin Receptor Blockers (ARB) are associated with worse outcomes in COVID-19 through …

中文翻译：

---

更正：英国胸科学会冬季会议 2021 年 11 月

摘要因未在会议上提交而被撤回 P39 - 分子方法的进步能否改善非结核分枝杆菌肺病 (NTM-LD) 的管理和结果？在英格兰一家大型教学医院对 NTM-LD 的实验室和临床管理进行服务评估 对摘要中的文本进行修订 P189 - 在 COVID-19 感染中使用血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂不会对临床结果产生不利影响，包括需要无创和有创通气简介据推测，使用血管紧张素转换酶抑制剂 (ACE-I) 和血管紧张素受体阻滞剂 (ARB) 与 COVID-19 的不良结果相关...